The DNA/RNA helicase DHX9 contributes to the transcriptional program of the androgen receptor in prostate cancer.
Lidia ChelliniMarco PieraccioliClaudio SetteMaria Paola ParonettoPublished in: Journal of experimental & clinical cancer research : CR (2022)
Collectively, our data uncover a new role of DHX9 in the control of the AR transcriptional program and establish the existence of an oncogenic DHX9/AR axis, which may represent a new druggable target to counteract PC progression.